How do you pay?

How to pay the least

Lowest price

$3,220.01 for 30 tablets

Generic emtricitabine, rilpivirine, and tenofovir disoproxil 200 mg / 25 mg / 300 mg with the free Team Cuban Card, at pharmacies that take it

  1. Get the free Team Cuban Card. It costs nothing to sign up.See the price and get the card 
  2. At a pharmacy that takes it, show the card and ask for generic emtricitabine, rilpivirine, and tenofovir disoproxil 200 mg / 25 mg / 300 mg.Find a pharmacy that takes it 

A regular generic has the same active ingredient as Complera, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameComplera
Authorized genericemtricitabine, rilpivirine, and tenofovir disoproxil
Regular genericemtricitabine, rilpivirine, and tenofovir disoproxil
What you’d pay
At least$3,900for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Lowest$3,220.01for 30 tablets at Team Cuban Card
Same as Complera?
The original
–
Same active ingredientFillers and dyes can differ

Brand nameThe maker’s card

Gilead Advancing Access Co-pay Savings Program

Savings card from Gilead Sciences

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on gilead.com 

Or call 1-866-664-5327.

In the maker’s words

“Eligible patients could pay as little as $0 per month.”

From the maker’s offer on gilead.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Complera itself, from the same company, sold without the brand name, and usually for less. A regular generic is sold, with the same active ingredient: ask the pharmacy for its price.

See the regular generic →

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic emtricitabine, rilpivirine, and tenofovir disoproxil, lowest first.

Pick up in store

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericWho makes it

2 companies sell a generic of Complera that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Laurus Labs200 mg / 25 mg / 300 mg

    Has lactose

    How it looks, what’s in it, NDCs

    200 mg / 25 mg / 300 mg White to off white, capsule, 19 mm, marked “LCT”

    PackageNDC
    Bottle of 3042385-801-30

    Inactive ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polysorbate 20, povidone k30, polyethylene glycol 3350, polyvinyl alcohol, talc, titanium dioxide

    FDA label

  • Mylan Pharmaceuticals200 mg / 25 mg / 300 mg

    Has lactose

    How it looks, what’s in it, NDCs

    200 mg / 25 mg / 300 mg Yellow, oval, 19 mm, marked “M / ERT”

    PackageNDC
    Bottle of 300378-5440-93

    Inactive ingredients: starch, corn, croscarmellose sodium, hypromellose 2910 (15000 mpa.s), lactose monohydrate, magnesium stearate, microcrystalline cellulose 101, microcrystalline cellulose 112, povidone k30, ferric oxide red, talc, titanium dioxide, triacetin, ferric oxide yellow

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What to say at the pharmacy

“Before you fill my Complera, can you tell me what I’d pay for the brand and for a generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

What it’s used for

What the FDA label says

COMPLERA, a combination of two nucleoside analog HIV-1 reverse transcriptase inhibitors (emtricitabine and tenofovir disoproxil fumarate) and one non-nucleoside reverse transcriptase inhibitor (rilpivirine), is indicated for use as a complete regimen for the treatment of HIV-1 infection in patients weighing at least 35 kg as initial therapy in those with no antiretroviral treatment history and with HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy, or or to replace a stable antiretroviral regiment in those who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least 6 months with no treatment failure and no known substitutions associated with resistance to the individual components of COMPLERA.

Limitations of Use:

  • More rilpivirine-treated subjects with HIV-1 RNA greater than 100,000 copies/mL at the start of therapy experienced virologic failure (HIV-1 RNA ≥50 copies/mL) compared to rilpivirine-treated subjects with HIV-1 RNA less than or equal to 100,000 copies/mL.

Source: the FDA label for Complera (Gilead Sciences, Inc.), July 16, 2025. Full label on DailyMed 

Good to know